Radiation Protection Dosimetry · 1989 · 41 citations · 0 references
PharmacyPharmacokineticsToxicologyBiochemical ToxicologyEnvironmental ToxicologyHeavy Metal ToxicologyActinide ChemistryBioinorganic ChemistryChelation TherapyIron ToxicologyLigand BindingAffinity LigandsDiethylenetriamine Pentaacetic Acid DerivativesLigand SelectivityMetal-binding PropertiesMetal-binding ProteinsPlasma Carrier ProteinsSequestering AgentsToxicant Sequestration
Binding of actinide (IV) by plasma proteins impedes excretion. Facilitation of elimination with chelating agents is the only known way to reduce carcinogenic risk. Iron-sequestering agents produced by micro-organisms contain metal-binding groups that bind Pu(IV) at pH 7.4 (catechol, CAM, in enterobactin; hydroxamate, X, in the ferrioxamines; hydroxpyridinone, HOPO). Our synthetic ligands contain up to four such groups linked by alkyl chains or attached to desferrioxamine (DFO) or diethylene-triamine-pentaacetic acid (DPTA). 238Pu excretion was tested in mice given 30 µmol.kg-1 of a ligand. Ligands that removed as much or more Pu than CaNa3-DTPA ((70% of injected Pu (% ID) are, in decreasing order of effectiveness: (1) Fe(III)-3,4,3-LIHOPO, (2) DFO-HOPO, (3) 3,4,3-LIHOPO, (4) 3,4,3-LICAM(C). Orally administered ligands 1-4, (5) 3,4,3-LICAM(S) and (6) ZnNa-DTPA-DX removed as much or more Pu than CaNa3-DTPA (( 15% ID). Ligands 1-4 and 6 injected 24 h after the Pu removed ( 5% ID more than control excretion (equivalent to or better than CaNa3-DTPA). All the new ligands at a dosage of 0.3 µmol.kg-1 removed a significant amount of Pu compared with controls: CaNa3-DTPA was ineffective. Ligand 3 is acutely toxic at high dosage, but the others appear to be of low toxicity. The HOPO ligands and ZnNa-DTPA-DX are recommended for further study.